Jesús María
Hernández Rivas
Catedrático de Universidad
Instituto de Salud Carlos III
Madrid, EspañaPublications in collaboration with researchers from Instituto de Salud Carlos III (6)
2022
-
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia
Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919
2021
-
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia
CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535
2020
-
Helpful criteria when implementing ngs panels in childhood lymphoblastic leukemia
Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-15
-
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia
British Journal of Haematology
2016
-
Uniparental disomy causes deficiencies of vitamin K-dependent proteins
Journal of Thrombosis and Haemostasis, Vol. 14, Núm. 12, pp. 2410-2418
2011
-
Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage
Blood Cells, Molecules, and Diseases, Vol. 46, Núm. 1, pp. 115-118